342 related articles for article (PubMed ID: 19758191)
21. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Li D; Song L; Fan Y; Li X; Li Y; Chen J; Zhu F; Guo C; Shi Y; Zhang L
Clin Immunol; 2009 Dec; 133(3):422-7. PubMed ID: 19748832
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
[TBL] [Abstract][Full Text] [Related]
23. [Phenomena and pathological significances of the methylated p16 promotor in DNA derived from plasma and blood cells of patients with systemic lupus erythematosus].
Li AS; Li YM; Yang AZ; Yao X; Chen ZQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):675-81. PubMed ID: 17121230
[TBL] [Abstract][Full Text] [Related]
24. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595
[TBL] [Abstract][Full Text] [Related]
26. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
[TBL] [Abstract][Full Text] [Related]
27. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus.
Ho CY; Wong CK; Li EK; Tam LS; Lam CW
J Rheumatol; 2002 Dec; 29(12):2537-44. PubMed ID: 12465148
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
Qing X; Putterman C
Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
[TBL] [Abstract][Full Text] [Related]
30. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
[TBL] [Abstract][Full Text] [Related]
31. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.
Deng YJ; Huang ZX; Zhou CJ; Wang JW; You Y; Song ZQ; Xiang MM; Zhong BY; Hao F
Mol Immunol; 2006 Mar; 43(9):1497-507. PubMed ID: 16143398
[TBL] [Abstract][Full Text] [Related]
32. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of autoimmune diseases by machine learning procedures.
Armañanzas R; Calvo B; Inza I; López-Hoyos M; Martínez-Taboada V; Ucar E; Bernales I; Fullaondo A; Larrañaga P; Zubiaga AM
IEEE Trans Inf Technol Biomed; 2009 May; 13(3):341-50. PubMed ID: 19423430
[TBL] [Abstract][Full Text] [Related]
34. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
Vieira QF; Kayser C; Kallas EG; Andrade LE
J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
[TBL] [Abstract][Full Text] [Related]
35. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
[TBL] [Abstract][Full Text] [Related]
36. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
37. Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?
De La Torre M; Urra JM; Blanco J
Lupus; 2009 Mar; 18(3):216-22. PubMed ID: 19213859
[TBL] [Abstract][Full Text] [Related]
38. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
Morello F; de Bruin TW; Rotter JI; Pratt RE; van der Kallen CJ; Hladik GA; Dzau VJ; Liew CC; Chen YD
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2149-54. PubMed ID: 15388524
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of gene expression patterns of periphery lymphocytes in patients with nasopharyngeal carcinoma].
Hong MH; Xiao XB; Mai HQ; Cao SM; Min HQ
Ai Zheng; 2002 Jan; 21(1):21-4. PubMed ID: 12500391
[TBL] [Abstract][Full Text] [Related]
40. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
